首页> 外国专利> NEW CRYSTAL OF 5-(1Z,2E)-2-METHYL-3-PHENYL-2-PROPENYLIDENE-4-OXO-2-THIOXO-3-THIAZOLIDINEACETIC ACID, METHOD FOR PRODUCING THE SAME, AND PHARMACEUTICAL WITH THE SAME AS ACTIVE INGREDIENT

NEW CRYSTAL OF 5-(1Z,2E)-2-METHYL-3-PHENYL-2-PROPENYLIDENE-4-OXO-2-THIOXO-3-THIAZOLIDINEACETIC ACID, METHOD FOR PRODUCING THE SAME, AND PHARMACEUTICAL WITH THE SAME AS ACTIVE INGREDIENT

机译:5-[(1Z,2E)-2-甲基-3-苯基-2-苯戊烯基] -4-氧代-2-硫代氧-3-硫代亚麻酸的新结晶,其制备方法以及与之相同的药物有效成分

摘要

PROBLEM TO BE SOLVED: To provide a uniform new crystal of 5-[(1Z,2E)-2-methyl-3-phenyl-2-propenylidene]-4-oxo-2-thioxo-3-thiazolidineacetic acid having high stability to light, to provide a method for producing the same, and to provide a pharmaceutical with the same as the active ingredient.;SOLUTION: The new A-type crystal of 5-[(1Z,2E)-2-methyl-3-phenyl-2-propenylidene]-4-oxo-2-thioxo-3-thiazolidineacetic acid has either one of the following physicochemical data shown in A, B and C below: (A) having a powder X-ray diffraction spectrum shown in Fig. 1, (B) the infrared absorption spectrum(IR) measured using reflection method is shown in Fig. 2, and (C) the result of differential scanning calorimetry(DSC) is shown in Fig. 3. The pharmaceutical contains the above new crystal as the active ingredient.;COPYRIGHT: (C)2004,JPO&NCIPI
机译:解决的问题:提供一种具有高稳定性的5-[(1Z,2E)-2-甲基-3-苯基-3-苯基-2-丙烯基] -4-氧代-2-硫代氧-3-噻唑烷乙酸的均匀新晶体光,以提供一种制备该药物的方法,并提供一种与该药物有效成分相同的药物。;解决方案:5-[(1Z,2E)-2-甲基-3-苯基的新型A型晶体-2-丙烯基] -4-氧代-2-硫代氧-3-噻唑烷乙酸具有以下A,B和C所示的以下任一物理化学数据:(A)具有图10所示的粉末X射线衍射光谱。图1中,(B)使用反射法测定的红外吸收光谱(IR)示于图2,(C)差示扫描量热法(DSC)的结果示于图3。该药物包含上述新晶体。作为有效成分。;版权所有:(C)2004,JPO&NCIPI

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号